{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,10]],"date-time":"2026-05-10T01:52:39Z","timestamp":1778377959271,"version":"3.51.4"},"reference-count":42,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001411","name":"Indian Council of Medical Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001411","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thrombosisresearch.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Thrombosis Research"],"published-print":{"date-parts":[[2021,12]]},"DOI":"10.1016\/j.thromres.2021.10.021","type":"journal-article","created":{"date-parts":[[2021,10,28]],"date-time":"2021-10-28T20:17:28Z","timestamp":1635452248000},"page":"92-98","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Serum thromboxane B2 but not soluble P-selectin levels identify ischemic stroke patients with persistent platelet reactivity while on aspirin therapy"],"prefix":"10.1016","volume":"208","author":[{"given":"Pandarisamy","family":"Sundaravadivel","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rita","family":"Christopher","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nitin","family":"Ramanujam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sadanandavalli Retnaswami","family":"Chandra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.thromres.2021.10.021_bb0005","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1007\/s11936-010-0075-8","article-title":"Thrombi of different pathologies: implications for diagnosis and treatment","volume":"12","author":"Santos-Gallego","year":"2010","journal-title":"Curr. Treat. Options Cardiovasc. Med."},{"key":"10.1016\/j.thromres.2021.10.021_bb0010","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/781857","article-title":"Overview of platelet physiology: its hemostatic and nonhemostatic role in disease pathogenesis","volume":"2014","author":"Ghoshal","year":"2014","journal-title":"Sci. World J."},{"key":"10.1016\/j.thromres.2021.10.021_bb0015","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1161\/STROKEAHA.118.023954","article-title":"Antiplatelet therapy in ischemic stroke and transient ischemic attack: an overview of major trials and meta-analyses","volume":"50","author":"Hackam","year":"2019","journal-title":"Stroke."},{"key":"10.1016\/j.thromres.2021.10.021_bb0020","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1136\/bmj.324.7329.71","article-title":"Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients","volume":"324","author":"Baigent","year":"2002","journal-title":"Br. Med. J."},{"key":"10.1016\/j.thromres.2021.10.021_bb0025","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1161\/01.CIR.0000045664.75269.A5","article-title":"Acetylsalicylic acid inhibits cell proliferation by involving transforming growth factor-\u03b2","volume":"107","author":"Redondo","year":"2003","journal-title":"Circulation."},{"key":"10.1016\/j.thromres.2021.10.021_bb0030","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.1016\/j.amjcard.2020.12.018","article-title":"Overview of aspirin and platelet biology","volume":"144","author":"Santos-Gallego","year":"2021","journal-title":"Am. J. Cardiol."},{"key":"10.1016\/j.thromres.2021.10.021_bb0035","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12883-016-0778-x","article-title":"Assessment of platelet function in patients with stroke using multiple electrode platelet aggregometry: a prospective observational study","volume":"16","author":"Sabra","year":"2016","journal-title":"BMC Neurol."},{"key":"10.1016\/j.thromres.2021.10.021_bb0040","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1159\/000503582","article-title":"Enhanced platelet reactivity under aspirin medication and major adverse cardiac and cerebrovascular events in patients with coronary artery disease","volume":"105","author":"Dannenberg","year":"2020","journal-title":"Pharmacology."},{"key":"10.1016\/j.thromres.2021.10.021_bb0045","doi-asserted-by":"crossref","first-page":"526","DOI":"10.3109\/09537104.2012.711865","article-title":"Advances in monitoring of aspirin therapy","volume":"23","author":"Lordkipanidz\u00e9","year":"2012","journal-title":"Platelets."},{"key":"10.1016\/j.thromres.2021.10.021_bb0050","doi-asserted-by":"crossref","first-page":"2636","DOI":"10.3390\/jcm9082636","article-title":"Advances in platelet function testing\u2014light transmission aggregometry and beyond","volume":"9","author":"Le Blanc","year":"2020","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.thromres.2021.10.021_bb0055","doi-asserted-by":"crossref","DOI":"10.1016\/j.amjcard.2006.09.008","article-title":"Current options in platelet function testing","volume":"98","author":"Michelson","year":"2006","journal-title":"Am. J. Cardiol."},{"key":"10.1016\/j.thromres.2021.10.021_bb0060","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1055\/s-0039-1688791","article-title":"Standardization of light transmission aggregometry for diagnosis of platelet disorders: an inter-laboratory external quality assessment","volume":"119","author":"Althaus","year":"2019","journal-title":"Thromb. Haemost."},{"key":"10.1016\/j.thromres.2021.10.021_bb0065","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1093\/eurheartj\/ehm232","article-title":"Laboratory detection of \u201caspirin resistance\u201d: what test should we use (if any)?","volume":"28","author":"Cattaneo","year":"2007","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.thromres.2021.10.021_bb0070","series-title":"Physiology, Thromboxane A2","author":"D.","year":"2019"},{"key":"10.1016\/j.thromres.2021.10.021_bb0075","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.3389\/fphar.2019.01244","article-title":"Measurement of thromboxane biosynthesis in health and disease","volume":"10","author":"Patrono","year":"2019","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.thromres.2021.10.021_bb0080","doi-asserted-by":"crossref","first-page":"1931","DOI":"10.1161\/01.CIR.102.16.1931","article-title":"P-selectin expression on platelets determines size and stability of platelet aggregates","volume":"102","author":"Merten","year":"2000","journal-title":"Circulation."},{"key":"10.1016\/j.thromres.2021.10.021_bb0085","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.cca.2008.09.018","article-title":"Soluble P-selectin as a marker of in vivo platelet activation","volume":"399","author":"Ferroni","year":"2009","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.thromres.2021.10.021_bb0090","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1097\/MCA.0b013e328360efd3","article-title":"Soluble P-selectin level correlates with acetylsalicylic acid but not with clopidogrel response in patients with stable coronary artery disease after a percutaneous coronary intervention","volume":"24","author":"Kaufmann","year":"2013","journal-title":"Coron. Artery Dis."},{"key":"10.1016\/j.thromres.2021.10.021_bb0095","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/S0002-9149(01)01631-9","article-title":"Profile and prevalence of aspirin resistance in patients with cardiovascular disease","volume":"88","author":"Gum","year":"2001","journal-title":"Am. J. Cardiol."},{"key":"10.1016\/j.thromres.2021.10.021_bb0100","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.amjmed.2006.08.023","article-title":"Aspirin resistance: is it real? Is it clinically significant?","volume":"120","author":"Dalen","year":"2007","journal-title":"Am. J. Med."},{"key":"10.1016\/j.thromres.2021.10.021_bb0105","doi-asserted-by":"crossref","first-page":"61","DOI":"10.3923\/jms.2001.61.62","article-title":"Development of a spectrophotometric method for the determination of aspirin in blood sample","volume":"1","author":"Ahmed","year":"2001","journal-title":"J. Med. Sci."},{"key":"10.1016\/j.thromres.2021.10.021_bb0110","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1159\/000315147","article-title":"Biochemical aspirin resistance and recurrent lesions in patients with acute ischemic stroke","volume":"64","author":"Jeon","year":"2010","journal-title":"Eur. Neurol."},{"key":"10.1016\/j.thromres.2021.10.021_bb0115","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1111\/j.1747-4949.2012.00929.x","article-title":"Aspirin resistance in Chinese stroke patients increased the rate of recurrent stroke and other vascular events","volume":"8","author":"Yi","year":"2013","journal-title":"Int. J. Stroke"},{"key":"10.1016\/j.thromres.2021.10.021_bb0120","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1001\/jamaneurol.2013.601","article-title":"Association of aspirin resistance with increased stroke severity and infarct size","volume":"70","author":"Zheng","year":"2013","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.thromres.2021.10.021_bb0125","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.jns.2017.03.010","article-title":"High on treatment platelet reactivity to aspirin and clopidogrel in ischemic stroke: a systematic review and meta-analysis","volume":"376","author":"Fiolaki","year":"2017","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.thromres.2021.10.021_bb0130","first-page":"E126","article-title":"Prevalence of aspirin resistance in Asian-Indian patients with stable coronary artery disease","volume":"88","author":"Chadha","year":"2016","journal-title":"Catheter. Cardiovasc. Interv."},{"key":"10.1016\/j.thromres.2021.10.021_bb0135","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1097\/MBC.0b013e3282f9ade8","article-title":"Major clinical vascular events and aspirin-resistance status as determined by the PFA-100 method among patients with stable coronary artery disease: a prospective study","volume":"19","author":"Christiaens","year":"2008","journal-title":"Blood Coagul. Fibrinolysis"},{"key":"10.1016\/j.thromres.2021.10.021_bb0140","doi-asserted-by":"crossref","first-page":"157","DOI":"10.14712\/18059694.2015.81","article-title":"Aspirin resistance in neurovascular diseases","volume":"57","author":"Vali\u0161","year":"2014","journal-title":"Acta Med. (Hradec Kralove)"},{"key":"10.1016\/j.thromres.2021.10.021_bb0145","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1016\/S0735-1097(02)03014-0","article-title":"A prospective, blinded determination of the natural history of aspirin resistance among stable patients with cardiovascular disease","volume":"41","author":"Gum","year":"2003","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.thromres.2021.10.021_bb0150","first-page":"1","article-title":"Monitoring of antiplatelet therapy in clinical practice: is it necessary or not?","volume":"02","author":"Marian Fedor","year":"2014","journal-title":"J. Hematol. Thromboembolic Dis."},{"key":"10.1016\/j.thromres.2021.10.021_bb0155","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1111\/jth.14445","article-title":"Obesity is associated with impaired responsiveness to once-daily low-dose aspirin and in vivo platelet activation","volume":"17","author":"Petrucci","year":"2019","journal-title":"J. Thromb. Haemost."},{"key":"10.1016\/j.thromres.2021.10.021_bb0160","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1016\/j.jacc.2005.06.058","article-title":"Platelet response to low-dose enteric-coated aspirin in patients with stable cardiovascular disease","volume":"46","author":"Maree","year":"2005","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.thromres.2021.10.021_bb0165","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1007\/s00392-004-0146-5","article-title":"P-selectin in arterial thrombosis","volume":"93","author":"Merten","year":"2004","journal-title":"Z. Kardiol."},{"key":"10.1016\/j.thromres.2021.10.021_bb0170","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1080\/09537104.2018.1445839","article-title":"Clinical utility of remote platelet function measurement using P-selectin: assessment of aspirin, clopidogrel, and prasugrel and bleeding disorders","volume":"29","author":"Bath","year":"2018","journal-title":"Platelets."},{"key":"10.1016\/j.thromres.2021.10.021_bb0175","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1097\/01.mbc.0000046182.72384.ab","article-title":"Aspirin inhibits surface glycoprotein IIb\/IIIa, P-selectin, CD63, and CD107a receptor expression on human platelets","volume":"14","author":"McKenzie","year":"2003","journal-title":"Blood Coagul. Fibrinolysis"},{"key":"10.1016\/j.thromres.2021.10.021_bb0180","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1046\/j.1365-2141.1998.00883.x","article-title":"Low-dose aspirin does not lower in vivo platelet activation in healthy smokers","volume":"102","author":"Pernerstorfer","year":"1998","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.thromres.2021.10.021_bb0185","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1212\/WNL.0b013e31820d62b5","article-title":"Increased risk of stroke after discontinuation of acetylsalicylic acid: a UK primary care study","volume":"76","author":"Garc\u00eda Rodr\u00edguez","year":"2011","journal-title":"Neurology."},{"key":"10.1016\/j.thromres.2021.10.021_bb0190","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s41983-019-0066-y","article-title":"Role of aspirin discontinuation in recurrence of ischemic cerebrovascular stroke","volume":"55","author":"Negm","year":"2019","journal-title":"Egypt. J. Neurol. Psychiatry Neurosurg."},{"key":"10.1016\/j.thromres.2021.10.021_bb0195","doi-asserted-by":"crossref","unstructured":"A. Hvas, E.L. Grove, Chapter 24 Platelet Function Tests: Preanalytical Variables, Clinical, in: 2017. https:\/\/doi.org\/10.1007\/978-1-4939-7196-1.","DOI":"10.1007\/978-1-4939-7196-1_24"},{"key":"10.1016\/j.thromres.2021.10.021_bb0200","series-title":"Methods Mol Biol","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1007\/978-1-4939-8597-5_12","article-title":"Badimon perfusion chamber: an ex vivo model of thrombosis","author":"Zafar MU","year":"2018"},{"key":"10.1016\/j.thromres.2021.10.021_bb0205","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fcvm.2021.684920","article-title":"Soluble platelet release factors as biomarkers for cardiovascular disease","volume":"8","author":"Baidildinova","year":"2021","journal-title":"Front. Cardiovasc. Med."},{"key":"10.1016\/j.thromres.2021.10.021_bb0210","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.119.013396","article-title":"Aspirin reduces the potentiating effect of CD40L on platelet aggregation via inhibition of myosin light chain","volume":"9","author":"Kojok","year":"2020","journal-title":"J. Am. Heart Assoc."}],"container-title":["Thrombosis Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049384821004941?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049384821004941?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,24]],"date-time":"2025-09-24T17:46:44Z","timestamp":1758736004000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0049384821004941"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12]]},"references-count":42,"alternative-id":["S0049384821004941"],"URL":"https:\/\/doi.org\/10.1016\/j.thromres.2021.10.021","relation":{},"ISSN":["0049-3848"],"issn-type":[{"value":"0049-3848","type":"print"}],"subject":[],"published":{"date-parts":[[2021,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Serum thromboxane B2 but not soluble P-selectin levels identify ischemic stroke patients with persistent platelet reactivity while on aspirin therapy","name":"articletitle","label":"Article Title"},{"value":"Thrombosis Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.thromres.2021.10.021","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}